Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 338: PLATINUM-CAN
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
-
CTN 339: The NOVA-HIV Study
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV
-
-
CTNPT 050: Perception of menopausal hormone therapy among women living with HIV
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
-
-
-
CTNPT 051: MindMap Feasibility Study
Optimizing HIV prevention for sexual and gender minorities seeking mental health supports: A feasibility study
-
CTNPT 043: Endocannabinoid system and inflamm-aging in HIV-associated atherosclerosis
Interplay between expanded endocannabinoid (eCB) system and inflamm-aging: Implication for accelerated atherosclerosis in people living with HIV (PLWH) under ART
-
CTN 334: Sex Now / Test Now 2022
Barriers and Facilitators of the “Sex Now 2022” Venue-Based HIV Self-Testing and Peer-Based Linkage to Care Intervention for Sexual Minority Men, Non-Binary, and Two-Spirit People
-
CTNPT 018: Adaptation and pilot of GPS among Latino gay positive men
Cultural Adaptation of Gay Poz Sex (GPS): A Positive Prevention Program for Gay, HIV-Positive Latino Men in Canada and Colombia
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More